XML 42 R60.htm IDEA: XBRL DOCUMENT v3.20.1
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS - Consolidated Statement of Changes in Equity (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   $ 7,803 $ 7,593 $ 7,866 $ 9,090 $ 8,830 $ 9,062 $ 9,109 $ 7,866 $ 9,109 $ 7,866 $ 9,109 $ 8,221
Beginning of year (in shares)   683,494,944 683,494,944 683,494,944 683,494,944 683,494,944 683,494,944   683,494,944   683,494,944    
Beginning of year (in shares)   173,275,586 173,447,198 170,495,859 150,213,621 148,485,202 146,993,164   170,495,859   170,495,859    
Adoption of new accounting standards       $ 0       (23) $ 0 (23) $ 0 (25)  
Net income attributable to Baxter stockholders $ (23) $ 369 $ 313 342 $ 305 $ 518 $ 341 382 655 723 1,001 1,546 602
Other comprehensive income (loss)     (4) (98)     (329) 115 (102) (214) 274 (281) 722
Purchases of treasury stock     (111) (586)     (259) (522) (697) (781) $ (1,247) $ (2,475) $ (564)
Purchases of treasury stock (in shares)                     16,500,000 35,800,000 9,200,000
Stock issued under employee benefit plans and other     123 166     123 85 289 208 $ 445 $ 354 $ 426
Dividends declared on common stock     (112) (98)     (102) (86) (210) (188) (435) (392) (334)
Distribution                         34
Changes in noncontrolling interests     1 1     (6) 2 2 (4) (2) 30 2
End of year $ 7,912   $ 7,803 $ 7,593 $ 7,866 $ 9,090 $ 8,830 $ 9,062 $ 7,803 $ 8,830 $ 7,912 $ 7,866 9,109
End of year (in shares) 683,494,944   683,494,944 683,494,944 683,494,944 683,494,944 683,494,944 683,494,944 683,494,944 683,494,944 683,494,944 683,494,944  
End of year (in shares) 177,340,358   173,275,586 173,447,198 170,495,859 150,213,621 148,485,202 146,993,164 173,275,586 148,485,202 177,340,358 170,495,859  
As previously reported                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   7,836 $ 7,669 $ 7,816 $ 9,113 $ 8,869 $ 9,093 $ 9,116 $ 7,816 $ 9,116 $ 7,816 $ 9,116 8,280
Adoption of new accounting standards       0       (19) 0 (19)   (21)  
Net income attributable to Baxter stockholders     343 347     343 389 690 732   1,624 717
Other comprehensive income (loss)     (77) 23     (323) 128 (54) (195)   (420) 555
Purchases of treasury stock     (111) (586)     (259) (522) (697) (781)   (2,475) (564)
Stock issued under employee benefit plans and other     123 166     123 85 289 208   354 426
Dividends declared on common stock     (112) (98)     (102) (86) (210) (188)   (392) (334)
Distribution                         34
Changes in noncontrolling interests     1 1     (6) 2 2 (4)   30 2
End of year     7,836 7,669 7,816 9,113 8,869 9,093 7,836 8,869   7,816 9,116
Restatement impacts                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   (33) (76) 50 (23) (39) (31) (7) 50 (7) 50 (7) (59)
Adoption of new accounting standards               (4)   (4)   (4)  
Net income attributable to Baxter stockholders     (30) (5)     (2) (7) (35) (9)   (78) (115)
Other comprehensive income (loss)     73 (121)     (6) (13) (48) (19)   139 167
End of year     (33) (76) 50 (23) (39) (31) (33) (39)   50 (7)
Common stock                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   $ 683 $ 683 $ 683   $ 683 $ 683 $ 683 $ 683 $ 683 $ 683 $ 683 $ 683
Beginning of year (in shares)   683,000,000 683,000,000 683,000,000   683,000,000 683,000,000 683,000,000 683,000,000 683,000,000 683,000,000 683,000,000 683,000,000
End of year $ 683   $ 683 $ 683 $ 683   $ 683 $ 683 $ 683 $ 683 $ 683 $ 683 $ 683
End of year (in shares) 683,000,000   683,000,000 683,000,000 683,000,000   683,000,000 683,000,000 683,000,000 683,000,000 683,000,000 683,000,000 683,000,000
Common stock | As previously reported                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   $ 683 $ 683 $ 683   $ 683 $ 683 $ 683 $ 683 $ 683 $ 683 $ 683 $ 683
Beginning of year (in shares)   683,000,000 683,000,000 683,000,000   683,000,000 683,000,000 683,000,000 683,000,000 683,000,000 683,000,000 683,000,000 683,000,000
End of year     $ 683 $ 683 $ 683   $ 683 $ 683 $ 683 $ 683   $ 683 $ 683
End of year (in shares)     683,000,000 683,000,000 683,000,000   683,000,000 683,000,000 683,000,000 683,000,000   683,000,000 683,000,000
Common stock | Restatement impacts                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   $ 0 $ 0 $ 0   $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
Beginning of year (in shares)   0 0 0   0 0 0 0 0 0 0 0
End of year     $ 0 $ 0 $ 0   $ 0 $ 0 $ 0 $ 0   $ 0 $ 0
End of year (in shares)     0 0 0   0 0 0 0   0 0
Common stock in treasury                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   $ (10,322) $ (10,284) $ (9,989)   $ (8,485) $ (8,354) $ (7,981) $ (9,989) $ (7,981) $ (9,989) $ (7,981) $ (7,995)
Beginning of year (in shares)   173,000,000 173,000,000 170,000,000   148,000,000 147,000,000 142,000,000 170,000,000 142,000,000 170,000,000 142,000,000 144,000,000
Purchases of treasury stock     $ (157) $ (586)     $ (259) $ (522) $ (743) $ (781) $ (1,293) $ (2,415) $ (564)
Purchases of treasury stock (in shares)     2,000,000 8,000,000     3,000,000 8,000,000 10,000,000 11,000,000 16,000,000 36,000,000 9,000,000
Stock issued under employee benefit plans and other     $ 119 $ 291     $ 128 $ 149 $ 410 $ 277 $ 518 $ 407 $ 578
Stock issued under employee benefit plans and other (in shares)     (2,000,000) (5,000,000)     (2,000,000) (3,000,000) (7,000,000) (5,000,000) 9,000,000 8,000,000 11,000,000
End of year $ (10,764)   $ (10,322) $ (10,284) $ (9,989)   $ (8,485) $ (8,354) $ (10,322) $ (8,485) $ (10,764) $ (9,989) $ (7,981)
End of year (in shares) 177,000,000   173,000,000 173,000,000 170,000,000   148,000,000 147,000,000 173,000,000 148,000,000 177,000,000 170,000,000 142,000,000
Common stock in treasury | As previously reported                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   $ (10,322) $ (10,284) $ (9,989)   $ (8,485) $ (8,354) $ (7,981) $ (9,989) $ (7,981) $ (9,989) $ (7,981) $ (7,995)
Beginning of year (in shares)   173,000,000 173,000,000 170,000,000   148,000,000 147,000,000 142,000,000 170,000,000 142,000,000 170,000,000 142,000,000 144,000,000
Purchases of treasury stock     $ (157) $ (586)     $ (259) $ (522) $ (743) $ (781)   $ (2,415) $ (564)
Purchases of treasury stock (in shares)     2,000,000 8,000,000     3,000,000 8,000,000 10,000,000 11,000,000   36,000,000 9,000,000
Stock issued under employee benefit plans and other     $ 119 $ 291     $ 128 $ 149 $ 410 $ 277   $ 407 $ 578
Stock issued under employee benefit plans and other (in shares)     (2,000,000) (5,000,000)     (2,000,000) (3,000,000) (7,000,000) (5,000,000)   (8,000,000) (11,000,000)
End of year     $ (10,322) $ (10,284) $ (9,989)   $ (8,485) $ (8,354) $ (10,322) $ (8,485)   $ (9,989) $ (7,981)
End of year (in shares)     173,000,000 173,000,000 170,000,000   148,000,000 147,000,000 173,000,000 148,000,000   170,000,000 142,000,000
Common stock in treasury | Restatement impacts                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   $ 0 $ 0 $ 0   $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
Beginning of year (in shares)   0 0 0   0 0 0 0 0 0 0 0
End of year     $ 0 $ 0 $ 0   $ 0 $ 0 $ 0 $ 0   $ 0 $ 0
End of year (in shares)     0 0 0   0 0 0 0   0 0
Additional contributed capital                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   $ 5,906 $ 5,839 $ 5,898   $ 5,916 $ 5,912 $ 5,940 $ 5,898 $ 5,940 $ 5,898 $ 5,940 $ 5,958
Purchases of treasury stock     46           46   46 (60)  
Stock issued under employee benefit plans and other     21 (59)     4 (28) (38) (24) 11 18 (18)
End of year $ 5,955   5,906 5,839 $ 5,898   5,916 5,912 5,906 5,916 5,955 5,898 5,940
Additional contributed capital | As previously reported                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   5,906 5,839 5,898   5,916 5,912 5,940 5,898 5,940 5,898 5,940 5,958
Purchases of treasury stock     46           46     (60) 0
Stock issued under employee benefit plans and other     21 (59)     4 (28) (38) (24)   18 (18)
End of year     5,906 5,839 5,898   5,916 5,912 5,906 5,916   5,898 5,940
Additional contributed capital | Restatement impacts                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   0 0 0   0 0 0 0 0 0 0 0
End of year     0 0 0   0 0 0 0   0 0
Retained earnings                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   15,598 15,414 15,075   14,484 14,254 14,014 15,075 14,014 15,075 14,014 13,846
Adoption of new accounting standards       161       (20) 161 (20) 161 (22)  
Net income attributable to Baxter stockholders     313 342     341 382 655 723 1,001 1,546 602
Stock issued under employee benefit plans and other     (17) (66)     (9) (36) (83) (45) (84) (71) (134)
Dividends declared on common stock     (112) (98)     (102) (86) (210) (188) (435) (392) (334)
Distribution                         34
End of year 15,718   15,598 15,414 15,075   14,484 14,254 15,598 14,484 15,718 15,075 14,014
Retained earnings | As previously reported                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   16,184 15,970 15,626   14,966 14,734 14,483 15,626 14,483 15,626 14,483 14,200
Adoption of new accounting standards       161       (16) 161 (16)   (18)  
Net income attributable to Baxter stockholders     343 347     343 389 690 732   1,624 717
Stock issued under employee benefit plans and other     (17) (66)     (9) (36) (83) (45)   (71) (134)
Dividends declared on common stock     (112) (98)     (102) (86) (210) (188)   (392) (334)
Distribution                         34
End of year     16,184 15,970 15,626   14,966 14,734 16,184 14,966   15,626 14,483
Retained earnings | Restatement impacts                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   (586) (556) (551)   (482) (480) (469) (551) (469) (551) (469) (354)
Adoption of new accounting standards               (4)   (4)   (4)  
Net income attributable to Baxter stockholders     (30) (5)     (2) (7) (35) (9)   (78) (115)
End of year     (586) (556) (551)   (482) (480) (586) (482)   (551) (469)
Accumulated other comprehensive income (loss)                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   (4,086) (4,082) (3,823)   (3,756) (3,427) (3,539) (3,823) (3,539) (3,823) (3,539) (4,261)
Adoption of new accounting standards       (161)       (3) (161) (3) (161) (3)  
Other comprehensive income (loss)     (4) (98)     (329) 115 (102) (214) 274 (281) 722
End of year (3,710)   (4,086) (4,082) (3,823)   (3,756) (3,427) (4,086) (3,756) (3,710) (3,823) (3,539)
Accumulated other comprehensive income (loss) | As previously reported                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   (4,639) (4,562) (4,424)   (4,199) (3,876) (4,001) (4,424) (4,001) (4,424) (4,001) (4,556)
Adoption of new accounting standards       (161)       (3) (161) (3)   (3)  
Other comprehensive income (loss)     (77) 23     (323) 128 (54) (195)   (420) 555
End of year     (4,639) (4,562) (4,424)   (4,199) (3,876) (4,639) (4,199)   (4,424) (4,001)
Accumulated other comprehensive income (loss) | Restatement impacts                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   553 480 601   443 449 462 601 462 601 462 295
Other comprehensive income (loss)     73 (121)     (6) (13) (48) (19)   139 167
End of year     553 480 601   443 449 553 443   601 462
Total Baxter stockholders' equity                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   7,779 7,570 7,844   8,842 9,068 9,117 7,844 9,117 7,844 9,117 8,231
Adoption of new accounting standards               (23)   (23)   (25)  
Net income attributable to Baxter stockholders     313 342     341 382 655 723 1,001 1,546 602
Other comprehensive income (loss)     (4) (98)     (329) 115 (102) (214) 274 (281) 722
Purchases of treasury stock     (111) (586)     (259) (522) (697) (781) (1,247) (2,475) (564)
Stock issued under employee benefit plans and other     123 166     123 85 289 208 445 354 426
Dividends declared on common stock     (112) (98)     (102) (86) (210) (188) (435) (392) (334)
Distribution                         34
End of year 7,882   7,779 7,570 7,844   8,842 9,068 7,779 8,842 7,882 7,844 9,117
Total Baxter stockholders' equity | As previously reported                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   7,812 7,646 7,794   8,881 9,099 9,124 7,794 9,124 7,794 9,124 8,290
Adoption of new accounting standards               (19)   (19)   (21)  
Net income attributable to Baxter stockholders     343 347     343 389 690 732   1,624 717
Other comprehensive income (loss)     (77) 23     (323) 128 (54) (195)   (420) 555
Purchases of treasury stock     (111) (586)     (259) (522) (697) (781)   (2,475) (564)
Stock issued under employee benefit plans and other     123 166     123 85 289 208   354 426
Dividends declared on common stock     (112) (98)     (102) (86) (210) (188)   (392) (334)
End of year     7,812 7,646 7,794   8,881 9,099 7,812 8,881   7,794 9,124
Total Baxter stockholders' equity | Restatement impacts                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   (33) (76) 50   (39) (31) (7) 50 (7) 50 (7) (59)
Adoption of new accounting standards               (4)   (4)   (4)  
Net income attributable to Baxter stockholders     (30) (5)     (2) (7) (35) (9)   (78) (115)
Other comprehensive income (loss)     73 (121)     (6) (13) (48) (19)   139 167
End of year     (33) (76) 50   (39) (31) (33) (39)   50 (7)
Noncontrolling interests                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   24 23 22   (12) (6) (8) 22 (8) 22 (8) (10)
Net income attributable to Baxter stockholders                     10    
Changes in noncontrolling interests     1 1     (6) 2 2 (4) (2) 30 2
End of year $ 30   24 23 22   (12) (6) 24 (12) 30 22 (8)
Noncontrolling interests | As previously reported                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   24 23 22   (12) (6) (8) 22 (8) 22 (8) (10)
Changes in noncontrolling interests     1 1     (6) 2 2 (4)   30 2
End of year     24 23 22   (12) (6) 24 (12)   22 (8)
Noncontrolling interests | Restatement impacts                          
Error Corrections and Prior Period Adjustments Restatement                          
Beginning of year   $ 0 0 0   $ 0 0 0 0 0 $ 0 0 0
End of year     $ 0 $ 0 $ 0   $ 0 $ 0 $ 0 $ 0   $ 0 $ 0